News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Judge Denies Delay in Pfizer Inc. (PFE) Chantix Trial



10/17/2012 8:36:29 AM

A federal judge in Alabama late Tuesday afternoon denied a request by Pfizer Inc. to delay by three months next week's start of a federal trial in a lawsuit that claims the pharmaceutical giant's anti-smoking drug Chantix caused a Minnesota man to commit suicide. "Given the current posture of this case, the court is of the opinion that a three-month continuance is not appropriate or needed," U.S. District Judge Inge Johnson wrote in her ruling. Judge's ruling: Pfizer made the request to delay the trial after the release today of a new clinical study on Chantix. Pfizer's motion seeking delay: The trial, which is to begin Monday in Florence, Ala., is set to be the first federal lawsuit to go before a jury out of more than 2,600 lawsuits filed so far against Pfizer over Chantix. The lawsuits, filed by smokers or their families, claim the drug has caused suicides, suicide attempts, or other psychological problems.

Read at Alabama Live
Read at Nasdaq
Read at Fox News


comments powered by Disqus
   
Addiction

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES